Carl Zeiss Meditec
€31.30Change from previous close: +0.32%Absolute change: +€0.10
At a glance
- Revenue growth
- +7.82%
- FY to Sep 2025 vs FY to Sep 2024
- Net income growth
- −20.99%
- FY to Sep 2025 vs FY to Sep 2024
- Net margin
- 6.3%
- FY to Sep 2024: 8.7%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | FY to Sep 2025 | FY to Sep 2024 | FY to Sep 2023 | FY to Sep 2022 |
|---|---|---|---|---|
| Total assets | 3,403 | 3,393 | 3,033 | 2,823 |
| Current assets | 1,272 | 1,208 | 1,912 | 1,792 |
| Cash and equivalents | 27.3 | 20.3 | 10.6 | 7.7 |
| Inventory | 497 | 536 | 520 | 383 |
| Net property, plant and equipment | 343 | 354 | 316 | 236 |
| Goodwill | 970 | 983 | 416 | 430 |
| Other intangible assets | 663 | 707 | 259 | 240 |
| Long-term investments | 28.9 | 20.4 | 21.5 | 10.8 |
| Current liabilities | 544 | 569 | 562 | 539 |
| Accounts payable | 194 | 184 | 240 | 189 |
| Total debt | 132 | 151 | 156 | 128 |
| Total liabilities | 1,276 | 1,337 | 860 | 793 |
| Total equity (incl. minority) | 2,128 | 2,056 | 2,173 | 2,030 |
| Retained earnings | 1,575 | 1,486 | 1,406 | 1,214 |
| Minority interest | 11.2 | 14.8 | 13.5 | 15.0 |